Triventures

About

Portfolio · 18

Descope Technologies

Authentication Platform for App Developers

2 rounds $88.0M committed Latest: 2025-09

TailorMed

End-to-end Financial Navigation Solution for Healthcare Providers

3 rounds $53.5M committed Latest: 2024-11

Monogoto

Software-defined Connectivity for IoT and Private Networks

2 rounds $38.0M committed Latest: 2024-10

BioProtect

Developer of a biodegradable balloon implant for prostate cancer radiation therapy.

2 rounds $53.0M committed Latest: 2023-09

FeelBetter

Polypharmacy Patient Management

Led ★ 2 rounds $7.4M committed Latest: 2023-07

FEMSelect

Treatment for Pelvic Floor Ligament Fixation

3 rounds $9.9M committed Latest: 2022-10

Genoox

Genomic Data Management Platform

1 round $8.0M committed Latest: 2021-05

EyeYon Medical

Ophthalmic Products for Vision-threatening Conditions

3 rounds $35.6M committed Latest: 2021-03

V-Wave

Miniature Shunt for Treating Congestive Heart Failure

2 rounds $126.0M committed Latest: 2020-09

Tunefork

Audio Personalization Based on Hearing Test

Led ★ 1 round $1.5M committed Latest: 2020-06

EarlySense

Contact-free Continuous Monitoring Solutions

1 round $39.0M committed Latest: 2019-01

Vi Labs

AI as a Service for Digital Health Companies

2 rounds $36.0M committed Latest: 2018-01

CathWorks

Noninvasive FFR Measurements for Coronary Interventions

Led ★ 1 round $15.8M committed Latest: 2017-10

Colospan

Technology for Colorectal Surgery

1 round $7.7M committed Latest: 2017-09

MST - Medical Surgery Technologies

Image-based Software for Robotic Surgery

1 round $12.5M committed Latest: 2015-07

Medisafe

Medication Management Platform

2 rounds $7.0M committed Latest: 2015-01

BioGaming

VR Physical Therapy Platform

1 round $3.7M committed Latest: 2014-11

Flow

Digital Marketplace for E&S Insurance

1 round $15.6M committed

Investment activity

7 portfolio exits on record.

Funds · 4

• Triventures ARC — $40M Sep 2019
• 4 — $40M Jun 2019
• 2 — $30M May 2015
• 3 — $75M May 2015

Q&A

What is Triventures' primary investment focus?

Triventures is a global, early-stage fund that invests in disruptive ventures with innovative breakthroughs in healthcare and beyond.

Which sectors does Triventures primarily invest in?

Triventures primarily invests in Health Tech & Life Sciences, accounting for 20 of its portfolio companies. They also have investments in Cyber Security, Business Software, and Fintech & Insurtech.

Can you name some of Triventures' recent notable exits?

Triventures has had several notable exits, including CathWorks, which was acquired by Medtronic for $585M in February 2026, and BioProtect, acquired by Almeda Ventures for $200M in January 2026.

What are some of the investment stages Triventures participates in?

Triventures invests across various stages, including Pre-Seed, Seed, A Round, and B Round.

When was Triventures founded and where is it headquartered?

Triventures was founded in 2009 and is headquartered in Herzliya, Israel.

Who are the co-founders of Triventures?

The co-founders of Triventures are Martin Leon, Peter Fitzgerald, and Michal Geva.

What is the most recent fund raised by Triventures?

Triventures raised its Triventures ARC fund in September 2019, with an amount of $40M.

What was the acquisition value for Genoox, a Triventures portfolio company?

Genoox was acquired by Qiagen for $80M in May 2025.